Sandostatin LAR® Depot (octreotide acetate for injectable suspension): The Only Medical Therapy Proven to Shrink Tumors in Acromegaly
Sandostatin LAR® Depot, the number one prescribed somatostatin-analogue in the world, is the only medical therapy clinically shown to reduce tumor size in patients with acromegaly.
Help Take Control with Tumor Reduction
Sandostatin LAR® Depot is proven to do more to help manage acromegaly. That’s because in two studies, Sandostatin LAR® Depot has been clinically shown to shrink tumors. And it’s worth noting that none of the participants in these studies experienced an increase in tumor size while on treatment with Sandostatin LAR®.
Well-tolerated Over the Long Term
Sandostatin LAR® Depot is also proven to be well-tolerated over the long term. And Sandostatin LAR® Depot has been used to treat acromegaly for nearly a decade, so you can feel confident that you're getting well-tolerated treatment with a proven track record.
